Effects of tafamidis on exercise capacity, cardiac function and myocardial amyloid deposition in patients with transthyretin amyloid cardiomyopathy

被引：0

作者：

Rettl, R. Rene ^{[1
]}

Duca, F. ^{[1
]}

Binder, C. ^{[1
]}

Capelle, C. ^{[1
]}

Eslam, R. Badr ^{[1
]}

Aschauer, S. ^{[1
]}

Mascherbauer, J. ^{[1
]}

Hengstenberg, C. ^{[1
]}

Bonderman, D. ^{[1
]}

机构：

[1] Med Univ Vienna, Vienna, Austria

来源：

EUROPEAN JOURNAL OF HEART FAILURE | 2020年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：8 / 8

页数：1

共 50 条

[41] Long-term survival with tafamidis in patients with transthyretin amyloid cardiomyopathy [J].

Damy, T. ;

Elliott, P. ;

Gundapaneni, B. ;

Tai, S. See ;

Sultan, M. B. ;

Drachman, B. M. .

EUROPEAN HEART JOURNAL, 2020, 41 :2142-2142

[42] TREATING TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: A COMPARISON OF DIFLUNISAL AND TAFAMIDIS [J].

Gilad, Amir ;

Joshi, Tracy ;

Mendelson, Lisa ;

Berk, John ;

Sanchorawala, Vaishali ;

Ruberg, Frederick ;

Siddiqi, Omar ;

Gopal, Deepa .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) :3296-3296

[43] Tafamidis prevents deterioration of physical performance in patients with transthyretin amyloid cardiomyopathy [J].

Eslam, R. Badr ;

Capelle, C. ;

Rettl, R. ;

Dachs, T. ;

Binder, C. ;

Ligios, L. Camuz ;

Duca, F. ;

Alasti, F. ;

Wolzt, M. ;

Bonderman, D. .

EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 :399-399

[44] Tafamidis Free Acid 61 Mg in Patients With Transthyretin Amyloid Cardiomyopathy [J].

Nativi-Nicolau, Jose ;

van der Meer, Peter ;

Gundapaneni, Balarama ;

Sultan, Marla B. ;

Garcia-Pavia, Pablo .

CIRCULATION, 2020, 142

[45] Tafamidis medication adherence and persistence in patients with transthyretin amyloid cardiomyopathy in Japan [J].

Kato, Takao ;

Ines, Monica ;

Minamisawa, Masatoshi ;

Benjumea, Darrin ;

Keohane, Denis ;

Alvir, Jose ;

Kim, Ruth ;

Chen, Yong ;

Peixoto, Telma ;

Kent, Matthew ;

Wogen, Jenifer ;

Ishii, Tomonori ;

Crowley, Aaron ;

Sugino, Toshiya ;

Izumiya, Yasuhiro .

ESC HEART FAILURE, 2024, 11 (05) :2481-+

[46] Tafamidis Stabilizes Transthyretin and Improves Clinical Outcomes in Transthyretin Amyloid Cardiomyopathy [J].

Falk, Rodney ;

Maurer, Matthew ;

Fedson, Savitri ;

Judge, Daniel ;

Zeldenrust, Steven ;

Quyyumi, Arshed ;

Pano, Arian ;

Packman, Jeff ;

Grogan, Donna .

JOURNAL OF CARDIAC FAILURE, 2011, 17 (08) :S56-S56

[47] Tafamidis: A First-in-Class Transthyretin Stabilizer for Transthyretin Amyloid Cardiomyopathy [J].

Park, Jonathan ;

Egolum, Ugochukwu ;

Parker, Shanea ;

Andrews, Ebony ;

Ombengi, David ;

Ling, Hua .

ANNALS OF PHARMACOTHERAPY, 2020, 54 (05) :470-477

[48] Prognostic Role Of Cardiopulmonary Exercise Testing In Wild Type Transthyretin Amyloid Cardiomyopathy Patients Treated With Tafamidis [J].

Dalia, Tarun ;

Acharya, Prakash ;

Chan, Wan-Chi ;

Sauer, Andrew ;

Weidling, Robert ;

Fritzlen, John ;

Goyal, Amandeep ;

Miller, Dana ;

Porter, Charles ;

Shah, Zubair .

JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) :S21-S21

[49] Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial) [J].

Hanna, Mazen ;

Damy, Thibaud ;

Grogan, Martha ;

Stewart, Michelle ;

Gundapaneni, Balarama ;

Patterson, Terrell A. ;

Schwartz, Jeffrey H. ;

Sultan, Marla B. ;

Maurer, Mathew S. .

AMERICAN JOURNAL OF CARDIOLOGY, 2021, 141 :98-105

[50] Relationship of tafamidis binding site occupancy, transthyretin stabilization, and disease modification in tafamidis treated transthyretin amyloid cardiomyopathy patients [J].

Moody, A. T. ;

Tess, D. A. ;

Li, Z. ;

Bulawa, C. ;

Fleming, J. ;

Maurer, T. S. .

EUROPEAN HEART JOURNAL, 2022, 43 :956-956

← 1 2 3 4 5 →